The modern approach to endovascular carotid revascularisation

Procedural and post-procedural cerebral ischaemic events still represent the Achilles’ heel of carotid artery stenting (CAS). While the occurrence of periprocedural events has decreased with the use of embolic protection devices (EPDs) tailored to specific anatomic and clinical characteristics1, large-scale clinical data have shown that adverse neurological events in the post-procedural period still account for a significant proportion of all CAS-related neurological events.

The average risk of post-procedural ipsilateral stroke is still quite disconcerting, (i.e., 0.4% per year)2,3. This phenomenon could be related to plaque protrusion through stent struts, which occurs in up to two thirds of cases ...